Provided by Tiger Fintech (Singapore) Pte. Ltd.

Compugen

1.80
+0.13007.78%
Post-market: 1.820.0200+1.11%19:30 EDT
Volume:333.42K
Turnover:587.73K
Market Cap:168.36M
PE:-8.44
High:1.82
Open:1.74
Low:1.69
Close:1.67
52wk High:2.66
52wk Low:1.13
Shares:93.54M
Float Shares:91.62M
Volume Ratio:0.58
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2133
EPS(LYR):-0.1590
ROE:-35.66%
ROA:-11.43%
PB:3.35
PE(LYR):-11.32

Loading ...

Compugen Announces Interim Analysis Timeline for MAIA-Ovarian Trial of COM701 as Maintenance Therapy in Platinum-Sensitive Ovarian Cancer

Reuters
·
Oct 13

Compugen Ltd. Announces First-in-Human Clinical Trial of Anti-IL18BP Antibody COM503 in Advanced Solid Tumors at SITC 2025

Reuters
·
Oct 06

Compugen’s Shareholders Approve All Proposals at 2025 Annual Meeting

TIPRANKS
·
Sep 17

Compugen Ltd reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 06

Compugen Ltd. Announces Date for 2025 Annual General Meeting of Shareholders

Reuters
·
Aug 06

Compugen Q2 EPS $(0.08) Misses $(0.07) Estimate, Sales $1.257M Miss $3.952M Estimate

Benzinga
·
Aug 06

Compugen Ltd expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
Aug 04

Compugen Ltd. to Present Pooled Analysis of COM701 Phase 1 Trials in Platinum Resistant Ovarian Cancer at ESMO 2025

Reuters
·
Jul 28

Compugen Ltd. to Release Second Quarter 2025 Financial Results

Reuters
·
Jul 23

Compugen Ltd. Begins Dosing in Global COM701 Platform Trial for Platinum Sensitive Ovarian Cancer

Reuters
·
Jul 21

Compugen Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 19

Compugen Q1 EPS $(0.08) Misses $(0.06) Estimate, Sales $2.28M Miss $3.70M Estimate

Benzinga
·
May 19

Compugen Ltd. Reports Slight Decline in Q1 2025 Revenues to $2.3M; Net Loss Narrowly Improves to $7.2M with EPS at $0.08

Reuters
·
May 19

Press Release: Compugen Reports First Quarter 2025 Results

Dow Jones
·
May 19

Compugen Ltd expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
May 16

Compugen Ltd. Announces Leadership Transition: Eran Ophir Named CEO, Anat Cohen-Dayag Appointed as Executive Chair

Reuters
·
May 13

Press Release: Compugen Announces Leadership Transitions Effective September 2025

Dow Jones
·
May 13